Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 880 participants.

Also called NCT01538446

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 880 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01538446
Main results
  • Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial Lancet (London, England), 2016-10-22 DOI, PubMed 27581531
Other papers using this trial's data
  • Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC Trial American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021-11 DOI, PubMed 34191259

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01538446. Randomized; no masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2016-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel
Acronym
ANTARCTIC
Condition
Acute Coronary Syndrome
Intervention (Drug)
Modification of Prasugrel based on a biological assay
Intervention (Drug)
prasugrel / clopidogrel
Intervention (Device)
Verify Now
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)
Collaborator
Eli Lilly and Company (class: industry)
Collaborator
Daiichi Sankyo (class: industry)
Collaborator
Allies in Cardiovascular Trials Initiatives and Organized (class: other)
Collaborator
Accumetrics, Inc. (class: industry)
Collaborator
Stentys (class: industry)

Record details

Record id
cardio:ct-nct01538446
Content hash
4cd7c55c7afd045d15cc6d0445fbd7e1cfb3de969a9d3a46579f9d0322b58b0f